abstract |
The present invention provides compounds of formula (I), their use as a p53-MDM2 interaction inhibitor, as well as pharmaceutical compositions comprising said compounds of formula (I) (See Formula I) in which n, m, p, r, s, t, R1, R2, R3, R4, R5, R6, R7, X, Y, Q and Z have defined meanings. |